IP-10 predicts the first phase decline of HCV RNA and overall viral response to therapy in patients co-infected with chronic hepatitis C virus infection and HIV

By Falconer Karolin   Askarieh Galia   Weis Nina   Hellstrand Kristoffer   Alaeus Annette   Lagging Martin    

Scandinavian Journal of Infectious Diseases, Vol. 42, Iss. 11-12, 2010-12 ,pp. : 896-901

Informa Healthcare

Access to resources Recommend Favorite

Use of a hepatitis C virus (HCV) RNA‐positive donor in a treated HCV RNA‐negative liver transplant recipient

By  

TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol. 20, Iss. 1, 2018-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Randomized trial of interferon‐ and ribavirin‐free ombitasvir/paritaprevir/ritonavir in treatment‐experienced hepatitis C virus–infected patients

By  

HEPATOLOGY, Vol. 61, Iss. 5, 2015-05 ,pp. : 1523-1532

John Wiley & Sons Inc

Access to resources Recommend Favorite

The corrected donor age for hepatitis C virus–infected liver transplant recipients

By  

LIVER TRANSPLANTATION, Vol. 21, Iss. 8, 2015-08 ,pp. : 1022-1030

John Wiley & Sons Inc

Access to resources Recommend Favorite

Role of hepatitis B virus, hepatitis D virus and other determinants on suppression of hepatitis C viraemia in HIV infected patients with chronic HCV infection: A longitudinal evaluation

By Antonucci Giorgio   Vairo Francesco   Iacomi Fabio   Comandini Ubaldo Visco   Solmone Mariacarmela   Piselli Pierluca   Boumis Evangelo   Lauria Francesco Nicola   Capobianchi Maria Rosaria   Ippolito Giuseppe   Puro Vincenzo  

Scandinavian Journal of Infectious Diseases, Vol. 40, Iss. 11-12, 2008-11 ,pp. : 928-934

Informa Healthcare

Access to resources Recommend Favorite